Validation of ICD-9-CM Diagnostic Codes for Inflammatory Bowel Disease Among Veterans

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2009 Dec 25

PMID 20033847

Citations 45

Authors

Selvi Thirumurthi

Reezwana Chowdhury

Peter Richardson

Neena S Abraham

Affiliations

Soon will be listed here.

Abstract

Background: Inflammatory bowel disease (IBD) is well described among young whites and less so among the elderly and non-whites. Population-level data is required to assess outcomes among minority groups.

Aim: To validate diagnostic codes for IBD from the Department of Veterans Affairs.

Methods: National databases were used to identify local patients with Crohn's disease (CD) and ulcerative colitis (UC), the extra-intestinal manifestations and surgical procedures associated with IBD. Diagnosis was confirmed by manual chart abstraction. Multivariable logistic regression was used to derive diagnostic algorithms for CD and UC, which were then validated in an independent cohort.

Results: The test cohort of 3,827 patients (1,316 potential cases, 2,511 random controls) was predominantly male (94%), white (56%), and of age of 58 (standard deviation 15). The positive predictive value (PPV) of CD codes was superior (88-100%) to UC (50-93%). The accuracy of extra-intestinal manifestations and surgeries was poor (PPV 0-29%). ICD-9-CM code 555.x without 560.9 had a PPV of 91% for CD in the validation cohort. Code 556.x with age, gender, and race factors was highly predictive of UC (c-statistic 0.9, PPV of 81%).

Conclusion: VA administrative data can diagnose elderly and non-white patients with IBD.

Citing Articles

Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada.

Galanis E, Goshtasebi A, Hung Y, Chan J, Matsell D, Chapman K Can Commun Dis Rep. 2024; 49(7-8):229-309.

PMID: 38455876 PMC: 10917133. DOI: 10.14745/ccdr.v49i78a01.

Effectiveness and safety of prophylactic anticoagulation among hospitalized patients with inflammatory bowel disease.

Dawwas G, Cuker A, Schaubel D, Lewis J Blood Adv. 2024; 8(5):1272-1280.

PMID: 38163322 PMC: 10918481. DOI: 10.1182/bloodadvances.2023011756.

Assessing Phenotype Definitions for Algorithmic Fairness.

Sun T, Bhave S, Altosaar J, Elhadad N AMIA Annu Symp Proc. 2023; 2022:1032-1041.

PMID: 37128361 PMC: 10148336.

Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy.

Ingrasciotta Y, Isgro V, Foti S, Ientile V, Fontana A, LAbbate L Clin Epidemiol. 2023; 15:309-321.

PMID: 36936062 PMC: 10015969. DOI: 10.2147/CLEP.S383738.

Early Use of Biologics Reduces Healthcare Costs in Crohn's Disease: Results from a United States Population-Based Cohort.

Ungaro R, Naegeli A, Choong C, Shan M, Zheng X, Hunter Gibble T Dig Dis Sci. 2023; 69(1):45-55.

PMID: 36920668 DOI: 10.1007/s10620-023-07906-4.

References

Robertson D, Grimm I . Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 2001; 30(2):409-26. DOI: 10.1016/s0889-8553(05)70188-6. View

Selby J, Schmittdiel J, Grumbach K, Quesenberry Jr C . Racial and ethnic differences in a patient survey: patients' values, ratings, and reports regarding physician primary care performance in a large health maintenance organization. Med Care. 2000; 38(3):300-10. DOI: 10.1097/00005650-200003000-00007. View

Loftus Jr E, Silverstein M, Sandborn W, Tremaine W, Harmsen W, Zinsmeister A . Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000; 46(3):336-43. PMC: 1727835. DOI: 10.1136/gut.46.3.336. View

Loftus Jr E . Crohn's disease: why the disparity in mortality?. Gut. 2006; 55(4):447-9. PMC: 1856159. DOI: 10.1136/gut.2005.080283. View

Herrinton L, Liu L, Lafata J, Allison J, Andrade S, Korner E . Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis. 2007; 13(4):451-61. DOI: 10.1002/ibd.20021. View

Bernstein C, Blanchard J, Rawsthorne P, Wajda A . Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999; 149(10):916-24. DOI: 10.1093/oxfordjournals.aje.a009735. View

Veloso F, Carvalho J, Magro F . Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996; 23(1):29-34. DOI: 10.1097/00004836-199607000-00009. View

Loftus Jr E, Silverstein M, Sandborn W, Tremaine W, Harmsen W, Zinsmeister A . Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology. 1998; 114(6):1161-8. DOI: 10.1016/s0016-5085(98)70421-4. View

Munkholm P, Langholz E, Nielsen O, Kreiner S, Binder V . Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol. 1992; 27(7):609-14. DOI: 10.3109/00365529209000127. View

10.

Abreu M, Harpaz N . Diagnosis of colitis: making the initial diagnosis. Clin Gastroenterol Hepatol. 2007; 5(3):295-301. DOI: 10.1016/j.cgh.2006.12.032. View

11.

Abraham N, El-Serag H, Johnson M, Hartman C, Richardson P, Ray W . National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2005; 129(4):1171-8. DOI: 10.1053/j.gastro.2005.08.003. View

12.

Thirumurthi S, Desilva R, Castillo D, Richardson P, Abraham N . Identification of Helicobacter pylori infected patients, using administrative data. Aliment Pharmacol Ther. 2008; 28(11-12):1309-16. DOI: 10.1111/j.1365-2036.2008.03845.x. View

13.

Ananthakrishnan A, McGinley E, Binion D . Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2008; 15(2):182-9. DOI: 10.1002/ibd.20628. View

14.

Kashner T . Agreement between administrative files and written medical records: a case of the Department of Veterans Affairs. Med Care. 1998; 36(9):1324-36. DOI: 10.1097/00005650-199809000-00005. View

15.

Kramer J, Davila J, Miller E, Richardson P, Giordano T, El-Serag H . The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2007; 27(3):274-82. DOI: 10.1111/j.1365-2036.2007.03572.x. View

16.

Lapidus A . The changing epidemiology of inflammatory bowel diseases. Acta Gastroenterol Belg. 2001; 64(2):155-9. View